You are required to be logged in to access the full website
Click here if you have forgotten your username or password
8 July 2026 - US-based therapeutics company Keenova Therapeutics plc on Wednesday reported positive Phase 3 results for XIAFLEX, its collagenase treatment for plantar fibromatosis, a chronic condition characterised by collagen-based nodules in the fo...
8 July 2026 - Healthcare solutions provider GE HealthCare Technologies Inc (NASDAQ: GEHC) and non-profit organisation Mayo Clinic announced on Wednesday the launch of the MI-BET (Molecular Imaging Biomarker-Based End of Therapy Trial) research collab...
8 July 2026 - Enterprise genomics company Helix announced on Tuesday a multi-year relationship with biopharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (NYSE:AZN).Under this agreement AstraZeneca will gain access to Helix's continuousl...
8 July 2026 - Clinical-stage biotechnology company Insilico Medicine (HKEX:3696) announced on Tuesday the initiation of the Phase III clinical trial for Rentosertib, its potentially first-in-class oral small-molecule inhibitor targeting TNIK for the ...
8 July 2026 - Invictus Pharmacy, a pharmacy platform managed by Invictus Ventures Inc, and Mullan Pharmaceutical Inc, a pharmaceutical company focused on expanding access to FDA-approved medications through high-capacity manufacturing partnerships an...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe